Every day, the information that is generated regarding the enormous servility that, in general, the medical class renders to the pharmaceutical industry, is so overwhelming that The noise can no longer hide the nuts.
According to the analysis in one of the reports of the Mad in America (MIA)between 2014 and 2020, 62 American psychiatrists were identified as receiving direct payments from pharmaceutical companies for a cumulative total of just over $1 million in that period. These psychiatrists, included in what was called the million dollar club They worked for the industry as speakers, consultants, or marketing advisors, among other things.
In a much larger study, which would cover from 2015 to 2021, data was found in said report on the payment of some 357.9 million dollars that the pharmaceutical industry would have paid to American psychiatrists; although once again the distribution was quite unequal, because 1% of psychiatrists received 74.7% of the payments.
Clearly, in all the databases consulted, it is impossible to define who is part of that club, although it would not be strange if, by reviewing the headlines of the different publications, the participants in television talk shows or those who give regular lectures at different conferences, a ranking of at least 600 individuals could be drawn up.
There is a file called Open Payments Database, where you can find information clarifying that the vast majority of American psychiatrists would not charge anything at all. Although this statement would hide a small trap since meals, trips or gifts in kind are not quantified as money.
In a book by the Professor of Therapeutics and Clinical Pharmacology of the Autonomous University of Bellaterra, Joan Ramón Laporte, Chronicle of an intoxicated society, comments: The clinical psychiatry journal that receives the most citations in the world is the Journal of Clinical Psychiatry. Where are they published? the results of clinical trials with new psychotropic drugs, as well as articles on the review of these products when they are marketed. Between 2014 and 2020, 17 board members and directors of the American Society of Clinical Psychopharmacology, publisher of the journal, received almost eight million dollars from psychotropic drug manufacturing companies.
That is, said publication would not exist without the real support of the psychopharmaceutical industry. And the industry needs experts to endorse its research on new drugs, even if they are dangerous.
In said book by Laporte, he states the following: SSRI drugs increase the risk of suicide, especially in children and adolescents. It is precisely the opposite of what should be expected from a truly antidepressant drug. And, although I have already published references to this type of drugs (SSRIs) on occasion, it does not hurt to return to this topic again, especially because it is dangerous.
SSRIs are Selective Serotonin Reuptake Inhibitors, a group of medications almost always used to treat depression and anxiety disorders. Let’s see a brief explanation of how they work and what they produce in our body.
In the brain, neurons release serotonin, a neurotransmitter related to mood. After this release (of serotonin), the same neuron normally “recaptures” it. What SSRI medications do is block this reuptake, which increases the amount of serotonin available in the body, so that neuronal connections are established. This increase usually improves mood and reduces anxiety.
Generally, these medications should be used sparingly, however the psychopharmacological industry, through doctors and various specialists, usually uses them for all types of unclassifiable ailments. Although they are administered without order or control in major depressions (whatever you mean by major depression), anxiety disorders (generalized anxiety, panic, phobias of all kinds, etc. Anyone could at any given time be a recipient of an SSRI, even without knowing it), obsessive compulsive disorder (OCD- something that can range from biting a nail, to any other issue that the “experts” consider), post-traumatic stress disorder (PTSD – a way any other to get rid of people who have suffered in certain circumstances, and instead of trying to help them, solving their lives, we medicate them, classify them as sick and throw them out on the streets or lock them in clinics), sometimes they are also prescribed for chronic pain or eating disorders or premenstrual dysphoric disorders. In short, any ailment that generates anxiety or fear could fall within the spectrum and be used against you, such medications never work in your favor. NEVER.
It never hurts for us to know which are the most well-known or common SSRI medications: Fluoxetine (PROZAC), Sertraline (ZOLOFT), Citalopram (CELEXA), Escitalopram (LEXAPRO), Paroxetine (PAXIL) and Fluvoxamine, among others.
Without going into the contraindications, which are many and varied, let me return to the book Chronicle of an intoxicated society, to recover the aforementioned phrase and continue with the terrifying paragraph that precedes it: SSRI drugs increase the risk of SUICIDE, especially in children and adolescents. It is precisely the opposite of what should be expected from a truly antidepressant drug. The titular companies (owners) They have known it for a long time. And yet the commercial promotion of the use of these drugs in children and adolescents continues. And it has effect. In 2014 in the US, 3.4% of adolescents took antidepressants.
In the last two decades, antidepressants have doubled in European countries, placing at the head of a hypothetical ranking, which I am not going to focus on, countries like Iceland, with 157 doses per 1,000 inhabitants and Spain with 98.8 doses per 1,000 inhabitants as well. The business is growing and the pharmaceutical industry is rubbing its hands, as are those who serve them.
Is it necessary to be critical of this issue? Yes. Our health is involved, especially mental health.
Originally published at LaDamadeElche.com
